Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiple sclerosis and autoimmune diseases - a case control study.
Wawrzyniak S, Rakoca M, Kułakowska A, Bartosik-Psujek H, Koziarska D, Kapica-Topczewska K, Kubicka-Bączyk K, Adamczyk-Sowa M. Wawrzyniak S, et al. Neurol Neurochir Pol. 2023;57(4):344-351. doi: 10.5603/PJNNS.a2023.0038. Epub 2023 Jun 21. Neurol Neurochir Pol. 2023. PMID: 37341190 Free article.
Uraemic autonomic neuropathy.
Bartosik-Psujek H, Psujek M, Mitosek-Szewczyk K. Bartosik-Psujek H, et al. Ann Univ Mariae Curie Sklodowska Med. 1996;51:133-8. Ann Univ Mariae Curie Sklodowska Med. 1996. PMID: 9467260 Review.
Markers of inflammation in cerebral ischemia.
Bartosik-Psujek H, Belniak E, Stelmasiak Z. Bartosik-Psujek H, et al. Neurol Sci. 2003 Nov;24(4):279-80. doi: 10.1007/s10072-003-0156-5. Neurol Sci. 2003. PMID: 14658049
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial.
Schoser B, Roberts M, Byrne BJ, Sitaraman S, Jiang H, Laforêt P, Toscano A, Castelli J, Díaz-Manera J, Goldman M, van der Ploeg AT, Bratkovic D, Kuchipudi S, Mozaffar T, Kishnani PS; PROPEL Study Group. Schoser B, et al. Lancet Neurol. 2021 Dec;20(12):1027-1037. doi: 10.1016/S1474-4422(21)00331-8. Lancet Neurol. 2021. PMID: 34800400 Clinical Trial.
128 results